About
Davis holds a bachelor's degree in finance from Miami University, an MBA from Northwestern University's Kellogg School of Management and a law degree from Northwestern University Pritzker School of Law. He spent about 14 years at Eli Lilly and Company, then joined Baxter in 2004, where he rose to president of the medical products business. At Merck he took over information technology and procurement in 2016 to form Global Services. He succeeded Kenneth Frazier as chairman. Other pharmaceutical leaders with pages on Whoo include Albert Bourla of Pfizer and David Ricks of Eli Lilly.
Whoo compiled this page from public sources: Merck leadership biography, Merck company leadership page, BioSpace. It is not affiliated with or endorsed by Rob Davis. Are you Rob Davis? Claim this page, or write to [email protected] to correct or remove it. Last updated: 2026-11-17.
Want a page like this? Create yours from your résumé.
Experience
Chairman and Chief Executive Officer — Merck
CEO from July 2021; chairman from December 2022 | Rahway, New Jersey
- Became president in April 2021 and joined the board when he took the CEO role
- Joined as CFO in 2014, also overseeing corporate strategy and business development
- Formed Global Services in 2016 by adding information technology and procurement
- Earlier led the renal business and served as chief financial officer and treasurer
- Held a variety of roles
Chief Financial Officer and Global Services lead — Merck
From 2014
Corporate Vice President and President, Medical Products — Baxter
2004 – 2014
Eli Lilly and Company
About 14 years before 2004